8 results on '"Soldevila, Berta"'
Search Results
2. Asistencia a la gestante con diabetes. Guía de práctica clínica actualizada en 2014
- Author
-
Acosta, Domingo, Balsells, Montserrat, Ballesteros, Mónica, Bandres, Maria Orosia, Bartha, Jose Luis, Bellart, Jordi, Chico, Ana Isabel, Codina, Mercedes, Corcoy, Rosa, Cortázar, Alicia, Donnay, Sergio, González, Nieves Luisa, Goya, Maria del Mar, Herranz, Lucrecia, López, José, Megía, Ana, Moreno, Eduardo, Mozas, Juan, Ontañón, Marta, Perea, Verónica, Ramirez, Octavio, Rossell, M<ce:sup loc='post">a</ce:sup> Rosa, Rubio, José Antonio, Sancho, M<ce:sup loc='post">a</ce:sup> Antonia, Soldevila, Berta, and Vinagre, Irene
- Published
- 2015
- Full Text
- View/download PDF
3. Detección de cáncer de tiroides mediante tomografía por emisión de positrones
- Author
-
Joaquín, Clara, Pellitero, Silvia, Soldevila, Berta, and Sanmartí, Anna
- Published
- 2006
- Full Text
- View/download PDF
4. Efecto de la infección VIH y el tratamiento antirretroviral en la metilación del ADN y la longitud telomérica: implicaciones sobre el envejecimiento biológico en las personas que viven con el VIH
- Author
-
Esteban Cantos, Andrés, Arribas López, José Ramón, Rodés Soldevila, Berta, UAM. Departamento de Bioquímica, and Instituto de Investigación Sanitaria del Hospital Universitario de La Paz (IdiPAZ)
- Subjects
Biociencias Moleculares ,Biología y Biomedicina / Biología - Abstract
Tesis Doctoral inédita leída en la Universidad Autónoma de Madrid, Facultad de Medicina, Departamento de Bioquímica. Fecha de Lectura: 25-05-2022, El desarrollo de la terapia antirretroviral (TAR) para el tratamiento de la infección por el VIH constituye uno de los principales logros de la medicina moderna. La enfermedad ha pasado de ser potencialmente mortal a ser una patología crónica y manejable. Sin embargo, en los últimos años se ha observado que las personas que viven con el VIH presentan, a pesar del control virológico y la mejoría inmunológica, una mayor prevalencia de comorbilidades relacionadas con el envejecimiento, sugiriendo que la enfermedad crónica podría estar asociada con un proceso de envejecimiento prematuro. Para evaluar cómo la infección VIH y el TAR interfieren en el envejecimiento biológico, en este trabajo hemos estudiado dos mecanismos moleculares que contribuyen en este proceso: la metilación del ADN y la longitud de los telómeros. En comparación con controles sin infección VIH, hemos observado que las personas que viven con el VIH sin TAR presentan una modificación en los perfiles de metilación del ADN, principalmente en genes relacionados con la regulación de la respuesta inmune. Utilizando 4 relojes epigenéticos como biomarcadores, también observamos que la infección VIH no tratada produce una aceleración del envejecimiento epigenético, que ocurre de forma más acusada en los pacientes con menores niveles de linfocitos T CD4+ y mayores cargas virales. Después de dos años desde el inicio del TAR, nuestros resultados han mostrado que los cambios en el metiloma asociados con la infección VIH tienden a normalizarse, y que la aceleración del envejecimiento epigenético se revierte parcialmente. En un análisis longitudinal realizado en personas que viven con el VIH tratadas y con supresión virológica prolongada, nuestros resultados han mostrado que durante la infección crónica bien controlada no se produce una aceleración del envejecimiento epigenético. Además, nuestros datos sugieren que los relojes epigenéticos podrían ser buenos candidatos como biomarcadores para predecir la aparición de comorbilidades relacionadas con el envejecimiento en el contexto de la infección VIH. Por último, en un estudio de corte transversal hemos observado que las personas que viven con el VIH y que llevaban más de 5 años tomando un régimen de TAR basado en tenofovir, tienen una menor actividad telomerasa en linfocitos T CD4+ y T CD8+ y una menor longitud telomérica en linfocitos T CD8+ que los pacientes que nunca han sido expuestos a tenofovir. Estos resultados podrían sugerir un efecto inhibitorio in vivo de la telomerasa por parte del tenofovir
- Published
- 2022
5. Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism.
- Author
-
Puig-Jové C, Castelblanco E, Falguera M, Hernández M, Soldevila B, Julián MT, Teis A, Julve J, Barranco-Altirriba M, Franch-Nadal J, Puig-Domingo M, Ortega E, Amigó N, Alonso N, and Mauricio D
- Subjects
- Cholesterol, HDL blood, Cholesterol, LDL blood, Cross-Sectional Studies, Female, Glucose, Humans, Male, Triglycerides blood, Diabetes Mellitus, Type 2 blood, Lipoproteins blood, Prediabetic State blood
- Abstract
Introduction and Objectives: Several types of lipoproteins beyond low-density lipoproteins (LDL) are causally related to cardiovascular disease. We aimed to analyze an advanced lipoprotein profile in individuals with normal and impaired glucose metabolism from different cohorts of a Mediterranean region., Methods: Cross-sectional study in 929 participants (463 normoglycemia, 250 prediabetes, and 216 type 2 diabetes mellitus) with normal renal function, free from cardiovascular disease, and without lipid-lowering treatment. Conventional and advanced (nuclear magnetic resonance [NMR] spectroscopy) lipoprotein profiles were analyzed., Results: Compared with men, normoglycemic women showed lower serum triglyceride and LDL cholesterol concentrations, lower total LDL particles (P) as well as their subclasses and their cholesterol and triglyceride content, higher high-density lipoproteins (HDL)-P and all HDL-related variables (P≤ .05 for all comparisons). Compared with normoglycemic participants, diabetic participants showed higher large and small very LDL-P concentrations (P <.05) and lower total HDL-P and medium HDL-P concentrations (P <.05). Waist circumference and Fatty Liver Index were positively associated with a proatherogenic profile., Conclusions: Women had a better advanced lipoprotein profile than did men. Adiposity indexes related to insulin-resistance were positively associated with a proatherogenic lipid profile. NMR revealed altered lipoprotein particles other than LDL in participants with diabetes, frequently associated with an increased cardiovascular risk. Our findings support the usefulness of extended lipoprotein analysis by NMR spectroscopy to uncover new therapeutic targets to prevent cardiovascular events in at-risk participants., (Copyright © 2021 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
6. Hypothyroidism during pregnancy and its association to perinatal and obstetric morbidity: a review.
- Author
-
Martínez M, Soldevila B, Lucas A, Velasco I, Vila L, and Puig-Domingo M
- Subjects
- Female, Humans, Infant, Newborn, Morbidity, Pregnancy, Hypothyroidism epidemiology, Neurodevelopmental Disorders epidemiology, Pregnancy Complications epidemiology
- Abstract
There is currently no consensus among the different scientific societies on screening for thyroid dysfunction in the first trimester of pregnancy. Indeed, diagnosis and treatment of subclinical hypothyroidism during pregnancy are controversial, as no cut-off value for thyrotropin (TSH) is universally accepted. TSH measurement may be influenced by different factors throughout pregnancy, but especially during the first trimester. The association between overt hypothyroidism during pregnancy and obstetric and perinatal complications is well established. It is also accepted that thyroid hormones are important for neurodevelopment of the offspring. However, there is no scientific evidence available about the impact of subclinical hypothyroidism and its treatment during the first trimester of pregnancy on children's neurodevelopment. In recent years, studies conducted in the offspring of mothers with subclinical hypothyroidism have reported new biochemical parameters which may eventually serve as biomarkers of offspring neurodevelopment and which are more reproducible and are measured at an earlier time than the conventional clinical tests., (Copyright © 2018 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
7. [Safety and tolerability of GLP-1 receptor agonists].
- Author
-
Soldevila B and Puig-Domingo M
- Subjects
- Animals, Antibody Formation drug effects, Blood Pressure drug effects, Carcinoma, Medullary chemically induced, Cardiotonic Agents pharmacology, Cardiotonic Agents therapeutic use, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2 complications, Gastrointestinal Motility drug effects, Glucagon-Like Peptide-1 Receptor, Heart drug effects, Humans, Hypoglycemia chemically induced, Hypoglycemic Agents therapeutic use, Lipids blood, Meta-Analysis as Topic, Nausea chemically induced, Pancreatitis chemically induced, Pancreatitis etiology, Rodentia, Species Specificity, Thyroid Neoplasms chemically induced, Vomiting chemically induced, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents adverse effects, Incretins agonists, Receptors, Glucagon agonists
- Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1ra) are a new group of drugs with a glucose-lowering action due to their incretin effect. The GLP-1 receptor is expressed in various human tissues, which could be related to the pleiotropic effects of human GLP-1, as well as to the adverse effects described in patients treated with GLP-1ra. The risk of hypoglycaemia is low, which is one of the main considerations in the safety of this family of compounds and is also important to patients with diabetes. The most frequent adverse effect is nausea, which usually occurs at the start of treatment and is transient in 20-60% of affected patients. This article also reviews the information available on antibody formation, the potential effect on the thyroid gland, and the controversial association between this group of drugs with pancreatitis and cancer., (Copyright © 2014 Elsevier España, S.L.U. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
8. [Thyroid cancer detection by PET].
- Author
-
Joaquín C, Pellitero S, Soldevila B, and Sanmartí A
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Positron-Emission Tomography, Thyroid Neoplasms diagnostic imaging
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.